Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53
- 1 January 2002
- journal article
- research article
- Published by Wiley in Journal of Experimental Therapeutics and Oncology
- Vol. 2 (1) , 19-26
Abstract
A variety of anticalmodulin drugs can increase the cytotoxicity of bleomycin, a DNA damaging cancer chemotherapeutic. The combination has been shown to produce greater than expected DNA damage compared wot what was observed with either drug alone. Promising preclinical results led to Phase I and Phase II trials of trifluoperazine and bleomycin, which revealed activity in non‐Hodgkin's lymphoma. Despite the unique activity of the combination, the mechanism underlying the DNA damaging effect remained poorly understood. In several systems, DNA damage leads to the induction of programmed cell death or apoptosis, which is characterized by interoligonucleosomal cleavage of DNA. To determine whether the activity of the combination of bleomycin with trifluoperazine was due to induction of apoptosis, we exposed L1210 leukemic lymphocytes to bleomycin in the presence or absence of trifluoperazine. The combination produced DNA laddering, cellular shrinkage, and chromatin condensation typical of programmed cell death. Cell cycle analyses revealed a blockade of cells in G2/M, suggesting the presence of mutant p53, which was confirmed by immunoanalysis. In addition, L1210 cells were found not to overexpress Bcl‐2 in the presence or absence of drugs. These results indicate that the enhancement of bleomycin induced DNA damage by trifluoperazine is mediated, at least in part, through the induction of apoptosis.Keywords
This publication has 38 references indexed in Scilit:
- Cell Death in DevelopmentCell, 1999
- Intracellular Calcium Levels Influence Apoptosis in Mature Sensory Neurons after Trophic Factor DeprivationExperimental Neurology, 1996
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- Tumor necrosis factor-α up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell linesInternational Immunology, 1995
- Calcium, calmodulin and cell cycle regulationFEBS Letters, 1994
- Elongation factor‐2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporineFEBS Letters, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro.Journal of Clinical Investigation, 1993
- Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulinLife Sciences, 1985
- Calmodulin and cell proliferationBiochemical and Biophysical Research Communications, 1982